Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Clinical markers of post-Chikungunya chronic inflammatory joint disease: A Brazilian cohort.

< BACK TO ARCHIVE


2023 Jan 06


PLoS Negl Trop Dis


http://www.ncbi.nlm.nih.gov/pubmed/36608155?dopt=Abstract


17


1

Clinical markers of post-Chikungunya chronic inflammatory joint disease: A Brazilian cohort.

Authors

Clinical markers of post-Chikungunya chronic inflammatory joint disease: A Brazilian cohort.
Lázari C D S, Ramundo M S, Ten-Caten F, Bressan CS, Bispo de Filippis A M, Manuli E R, de Moraes I, Pereira G M, Côrtes M F, da Candido D S, Gerber AL, Guimarães A P, Faria N R, Nakaya HI, Vasconcelos A TR, Brasil P, Paranhos-Baccalà G, Sabino E C
PLoS Negl Trop Dis. 2023 Jan 06; 17(1):e0011037.
PMID: 36608155.

Abstract

Chikungunya-fever (CHIKF) remains a public health major issue. It is clinically divided into three phases: acute, post-acute and chronic. Chronic cases correspond to 25-40% individuals and, though most of them are characterized by long-lasting arthralgia alone, many of them exhibit persistent or recurrent inflammatory signs that define post-Chikungunya chronic inflammatory joint disease (pCHIKV-CIJD). We aimed to identify early clinical markers of evolution to pCHIKV-CIJD during acute and post-acute phases.
Read This Paper